The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

The FDA has lifted its previously recommended pause on the use of the Chikungunya virus vaccine in individuals 60 and older, following a benefit-risk assessment. The agency also approved updated ...

A new CDC report shows rates of vaccination and vaccine exemptions for the 2024 to 2025 school year. Here's what experts say ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older ...

Such is the position of Professor Russell Stewart ( pictured ), who lost his job after his opposition to Minnesota Gov. Tim ...

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

Health and Human Services Secretary Robert F. Kennedy Jr. accepted a vote by a federal immunization panel to recommend the influenza vaccine for children, pregnant women and all adults earlier ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...